Physiological evidence for β3-adrenoceptor in frog (Rana esculenta) heart

General and Comparative Endocrinology

Volumn 169, Issue 2, 2010, Pages 151-157

  Mazza, Rosa ^a   Angelone, Tommaso ^a   Pasqua, Teresa ^a   Gattuso, Alfonsina ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

CGMP; Isoproterenol; Nitric oxide; PDE2; PKG

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 3 ADRENERGIC RECEPTOR; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; NADOLOL; NITRIC OXIDE SYNTHASE; PERTUSSIS TOXIN; PHENTOLAMINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE 2; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOCARDIUM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; FROG; HEART FUNCTION; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 77957243144     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2010.08.003     Document Type: Article

References (35)

1. Acierno R., Gattuso A., Guerrieri A., Mannarino C., Amelio D., Tota B. Nitric oxide modulates the frog heart ventricle morphodynamics. Comp. Biochem. Physiol. A 2008, 151:51-60.
2. Angelone T., Filice E., Quintieri A.M., Imbrogno S., Recchia A., Pulera' E., Mannarino C., Pellegrino D., Cerra M.C. β3-Adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway. Acta Physiol. 2008, 193:229-239.
3. Bellantuono V., Cassano G., Lippe C. The adrenergic receptor subtypes present in frog (Rana esculenta) skin. Comp. Biochem. Physiol. C 2008, 148:160-164.
4. Cerra M.C., Angelone T., Parisella M.L., Pellegrino D., Tota B. Nitrite modulates contractility of teleost (Anguilla anguilla and Chionodraco hamatus, i.e. the Antarctic hemoglobinless icefish) and frog (Rana esculenta) hearts. Biochim. Biophys. Acta. 2009, 1787:849-855.
5. Cheng H.J., Zhang Z.S., Onishi K., Ukai T., Sane D.C., Cheng C.P. Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium. Circ. Res. 2001, 89:599-606.
6. Dinçer U.D., Bidasee K.R., Güner S., Tay A., Ozçelikay A.T., Altan V.M. The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts. Diabetes 2001, 50:455-461.
7. 2+ current to nitric oxide in frog ventricular myocytes. J. Physiol. 2001, 534:109-121.
8. Emorine L.J., Marullo S., Briend-Sutren M.M., Patey G., Tate K., Delavier-Klutchko C., Strosberg A.D. Molecular characterization of the human beta3-adrenergic receptor. Science 1989, 245:1118-1121.
9. Fischmeister R., Hartzell H.C. Cyclic guanosine 3′,5′monophosphate regulates the calcium current in single cells from frog ventricle. J. Physiol. 1987, 387:453-472.
10. Fischmeister R., Castro L., Abi-Gerges A., Rochais F., Vandecasteele G. Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels. Comp. Biochem. Physiol. A 2005, 142:136-143.
11. Gattuso A., Mazza R., Pellegrino D., Tota B. Endocardial endothelium mediates luminal ACh-NO signaling in isolated frog heart. Am. J. Physiol. Heart Circ. Physiol. 1999, 276:H633-H641.
12. Gauthier C., Leblais V., Kobzik L., Trochu J.N., Khandoudi N., Bril A., Balligand J.L., Marec H.L. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J. Clin. Invest. 1998, 102:1377-1384.
13. Gauthier C., Tavernier G., Charpentier F., Langin D., Le Marec H. Functional β3-adrenoceptor in the human heart. J. Clin. Invest. 1996, 98:556-562.
14. Gauthier C., Tavernier G., Trochu J.N., Leblais V., Laurent K., Langin D., Escande D., Le Marec H. Interspecies differences in the cardiac negative inotropic effects of β3-adrenoceptor agonists. J. Pharmacol. Exp. Ther. 1999, 290:687-693.
15. Gauthier C., Langin D., Balligand J.L. Beta3-adrenoceptors in the cardiovascular system. Trends Pharmacol. Sci. 2000, 21:426-431.
16. 2+ current in single heart cells. Nature 1986, 323:273-275.
17. Hartzell H.C., Méry P.F., Fischmeister R., Szabo G. Sympathetic regulation of cardiac calcium current is due exclusively to cAMP-dependent phosphorylation. Nature 1991, 351:573-576.
18. Imbrogno S., Angelone T., Adamo C., Pulerà E., Tota B., Cerra M.C. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism. J. Exp. Biol. 2006, 209:4966-4973.
19. Ca,L in frog ventricular myocytes. J. Physiol. 2003, 551:239-252.
20. Kitamura T., Onishi K., Dohi K., Okinaka T., Isaka N., Nakano T. The negative inotropic effect of β3-adrenoceptor stimulation in the beating guinea pig heart. J. Cardiovasc. Pharmacol. 2000, 35:786-790.
21. Lands A.M., Arnold A., McAuliff J.P., Luduena F.P., Brown T.J. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967, 214:597-598.
22. Lugnier C., Gauthier C., Le Bec A., Soustre H. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities. Am. J. Physiol. 1992, 262:H654-H660.
23. Mazza R., Gattuso A., Mannarino C., Brar B.K., Barbieri S.F., Tota B., Mahata S.K. Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H113-H122.
24. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. USA 1991, 88:1197-1201.
25. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J. Biol. Chem. 1993, 268:26286-26295.
26. Méry P.F., Pavoine C., Pecker F., Fischmeister R. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol. Pharmacol. 1995, 48:121-130.
27. Mongillo M., Tocchetti C.G., Terrin A., Lissandron V., Cheung Y.F., Dostmann W.R., Pozzan T., Kass D.A., Paolocci N., Houslay M.D., et al. Compartmentalized phosphodiesterase-2 activity blunts β-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway. Circ. Res. 2006, 98:226-234.
28. Nickerson J.G., Dugan S.G., Drouin G., Perry S., Moon T.W. Activity of the unique-adrenergic Na+/H+ exchanger in trout erythrocytes is controlled by a novel 3-AR subtype. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R526-R535.
29. Rozec B., Gauthier C. Beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol. Ther. 2006, 111:52-73.
30. Simmons M.A., Hartzell H.C. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes. Mol. Pharmacol. 1998, 33:664-671.
31. 2+ current in frog ventricular myocytes. Br. J. Pharmacol. 1997, 121:1277-1286.
32. 2+ current. J. Clin. Invest. 2008, 118:3219-3227.
33. 2+ current in rat ventricular myocytes. Circ. Res. 1995, 77:803-812.
34. Sys S.U., Pellegrino D., Mazza R., Gattuso A., Andries L.J., Tota B. Endocardial endothelium in the avascular heart of the frog: morphology and role of nitric oxide. J. Exp. Biol. 1997, 200:3109-3118.
35. Zaccolo M., Movsesian M.A. CAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ. Res. 2007, 100:1569-1578.